206640 — Boditech Med Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapContrarian

Annual cashflow statement for Boditech Med, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	47,395	25,281	26,668	27,220	23,880
Depreciation
Amortisation
Non-Cash Items	13,515	3,013	8,145	2,924	3,356
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-17,023	-12,699	-8,745	-13,707	-15,216
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	49,927	23,068	34,300	24,879	22,081
Capital Expenditures	-18,411	-16,905	-5,630	-12,468	-34,020
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	2,808	-7,549	-10,492	490	-14,281
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-15,603	-24,454	-16,122	-11,978	-48,301
Financing Cash Flow Items	-369	—	212	954	1,040
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-19,937	-10,162	-1,938	-7,976	-1,784
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	14,772	-12,555	16,232	5,450	-28,388